Literature DB >> 12424339

Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA.

R A Neese1, L M Misell, S Turner, A Chu, J Kim, D Cesar, R Hoh, F Antelo, A Strawford, J M McCune, M Christiansen, M K Hellerstein.   

Abstract

We describe here a method for measuring DNA replication and, thus, cell proliferation in slow turnover cells that is suitable for use in humans. The technique is based on the incorporation of (2)H(2)O into the deoxyribose (dR) moiety of purine deoxyribonucleotides in dividing cells. For initial validation, rodents were administered 4% (2)H(2)O in drinking water. The proliferation rate of mammary epithelial cells in mice was 2.9% per day and increased 5-fold during pregnancy. Administration of estradiol pellets (0-200 microg) to ovariectomized rats increased mammary epithelial cell proliferation, according to a dose-response relationship up to the 100 microg dose. Similarly, proliferation of colon epithelial cells was stimulated in a dose-response manner by dietary cholic acid in rats. Bromodeoxyuridine labeling correlated with the (2)H(2)O results. Proliferation of slow turnover cells was then measured. Vascular smooth muscle cells isolated from mouse aorta divided with a half-life in the range of 270-400 days and die-away values after (2)H(2)O wash-out confirmed these slow turnover rates. The proliferation rate of an adipocyte-enriched fraction from mouse adipose tissue depots was 1-1.5% new cells per day, whereas obese ad libitum-fed obob mice exhibited markedly higher fractional and absolute proliferation rates. In humans, stable long-term (2)H(2)O enrichments in body water were achieved by daily (2)H(2)O intake, without toxicities. Labeled dR from fully turned-over blood cells (monocytes or granulocytes) exhibited a consistent amplification factor relative to body (2)H(2)O enrichment ( approximately 3.5-fold). The fraction of newly divided naive-phenotype T cells after 9 weeks of labeling with (2)H(2)O was 0.056 (CD4(+)) and 0.043 (CD8(+)) (replacement rate <0.1% per day). In summary, (2)H(2)O labeling of dR in DNA allows safe, convenient, reproducible, and inexpensive measurement of cell proliferation in humans and experimental animals and is well suited for slow turnover cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424339      PMCID: PMC137719          DOI: 10.1073/pnas.232551499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.

Authors:  F M Waldman; K Chew; B M Ljung; W Goodson; J Hom; L A Duarte; H S Smith; B Mayall
Journal:  Mod Pathol       Date:  1991-11       Impact factor: 7.842

Review 2.  Interactions between deoxyribonucleotide and DNA synthesis.

Authors:  P Reichard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Glycoprotein metabolism in rat colonic epithelial cell populations with different proliferative activities.

Authors:  T A Brasitus; R S Keresztes
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

4.  Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: minimal estimates of production and turnover rates of mature lymphocytes.

Authors:  B Rocha; C Penit; C Baron; F Vasseur; N Dautigny; A A Freitas
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532

5.  Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans.

Authors:  D C Macallan; C A Fullerton; R A Neese; K Haddock; S S Park; M K Hellerstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis.

Authors:  W C Chang; R S Chapkin; J R Lupton
Journal:  Carcinogenesis       Date:  1997-04       Impact factor: 4.944

7.  Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism.

Authors:  A Cohen; J Barankiewicz; H M Lederman; E W Gelfand
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Stable isotopes in clinical research: safety reaffirmed.

Authors:  P J Jones; S T Leatherdale
Journal:  Clin Sci (Lond)       Date:  1991-04       Impact factor: 6.124

Review 9.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

Authors:  S Nandi; R C Guzman; J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Comparison of autoradiography, liquid scintillation counting and immunoenzymatic staining of 5-bromo-2'-deoxyuridine for measurement of unscheduled DNA synthesis and replicative DNA synthesis in rat liver.

Authors:  S Sawada; S Asakura; H Daimon; C Furihata
Journal:  Mutat Res       Date:  1995-10       Impact factor: 2.433

View more
  110 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/β-catenin signalling or lipolysis.

Authors:  M-H Kim; J-S Park; M-S Seo; J-W Jung; Y-S Lee; K-S Kang
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

Review 4.  Aging and T-cell diversity.

Authors:  Jörg J Goronzy; Won-Woo Lee; Cornelia M Weyand
Journal:  Exp Gerontol       Date:  2007-01-10       Impact factor: 4.032

Review 5.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

6.  In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

Authors:  Bradley T Messmer; Davorka Messmer; Steven L Allen; Jonathan E Kolitz; Prasad Kudalkar; Denise Cesar; Elizabeth J Murphy; Prasad Koduru; Manlio Ferrarini; Simona Zupo; Giovanna Cutrona; Rajendra N Damle; Tarun Wasil; Kanti R Rai; Marc K Hellerstein; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

7.  A stable isotope method for the simultaneous measurement of matrix synthesis and cell proliferation in articular cartilage in vivo.

Authors:  K W Li; S A Siraj; E W Cheng; M Awada; M K Hellerstein; S M Turner
Journal:  Osteoarthritis Cartilage       Date:  2009-02-07       Impact factor: 6.576

8.  Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

Authors:  Marc K Hellerstein; Rebecca A Hoh; Mary Beth Hanley; Denise Cesar; Daniel Lee; Richard A Neese; Joseph M McCune
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Dexamethasone-mediated changes in adipose triacylglycerol metabolism are exaggerated, not diminished, in the absence of a functional GR dimerization domain.

Authors:  Donald J Roohk; Smita Mascharak; Cyrus Khambatta; Ho Leung; Marc Hellerstein; Charles Harris
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

10.  Requirement for deoxycytidine kinase in T and B lymphocyte development.

Authors:  Gerald Toy; Wayne R Austin; Hsiang-I Liao; Donghui Cheng; Arun Singh; Dean O Campbell; Tomo-o Ishikawa; Lynn W Lehmann; Nagichettiar Satyamurthy; Michael E Phelps; Harvey R Herschman; Johannes Czernin; Owen N Witte; Caius G Radu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.